Roivant Sciences Ltd. (ROIV)
$34.59-2.40%Close
SELLBEAR · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $25.0B
- Beta
- 1.12
- P/E (TTM)
- -93.50
- Short % float
- 6.81%
- Days to cover
- 4.4
- SI change
- +8.6%
- 1W
- -3.33%
- 1M
- -15.26%
- vs SPY 1W
- -3.75%
- vs SPY 1M
- -17.32%
Industry peers
FMP comparable companies · ranked by market cap
- VRTXSELLVertex Pharmaceuticals Incorporated$129.5BBEARQ 23$510.08-0.60%
- MRNABUYModerna, Inc.$89.3BRECOVERYQ 36$225.00-5.00%
- REGNSELLRegeneron Pharmaceuticals, Inc.$76.9BBEARQ 24$746.54+2.18%
- BIIBBUYBiogen Inc.$33.3BBULLQ 19$225.71+1.64%
- ALNYSELLAlnylam Pharmaceuticals, Inc.$31.1BRECOVERYQ 28$232.68-2.43%
- BNTXSELLBioNTech SE$24.4BRECOVERYQ 35$96.96-1.16%
- UTHRBUYUnited Therapeutics Corporation$23.3BRECOVERYQ 20$549.16+0.17%
- INCYSELLIncyte Corporation$22.9BBEARQ 13$112.79-1.27%
- GMABBUYGenmab A/S$22.8BBULLQ 21$37.07+0.81%
- JAZZSELLJazz Pharmaceuticals plc$13.7BBEARQ 24$218.42-0.76%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ROIV?
- LOPJLB’s latest quantitative signal on Roivant Sciences Ltd. (ROIV) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is ROIV in?
- Roivant Sciences Ltd. (ROIV) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Roivant Sciences Ltd. (ROIV) do?
- Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditio…